Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating lung disease characterized by irreversible scarring of the lungs. The cause of IPF is unknown, but it is thought to involve a combination of genetic and environmental factors. There is no cure for IPF, and treatment is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadi, Dalia D., Marsool, Mohammed Dheyaa Marsool, Marsool, Ali Dheyaa Marsool, Vora, Neel, Al‐Badri, Sajjad G., Al‐Fatlawi, Nabeel H. K., Abbas Al Wssawi, Ameer F., Al‐Ibraheem, Abdullah M. T., Hamza, Khadija A., Prajjwal, Priyadarshi, Mateen, Mohammed A., Amir, Omniat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632947/
https://www.ncbi.nlm.nih.gov/pubmed/38018591
http://dx.doi.org/10.1002/iid3.1079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632947/
https://www.ncbi.nlm.nih.gov/pubmed/38018591
http://dx.doi.org/10.1002/iid3.1079

Ejemplares similares